ArticleMatrix biology : journal of the International Society for Matrix Biology2026
Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior.
Article in Matrix biology : journal of the International Society for Matrix Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The extracellular matrix (ECM) provides key biochemical and biomechanical cues that govern fundamental cellular processes, including growth and migration. ECM dysregulation and altered cell-matrix interactions are drivers of cancer progression, exemplified by pancreatic ductal adenocarcinoma (PDAC), where an abnormally dense, collagen-rich, and stiff ECM correlates with poor patient outcomes. The PDAC microenvironment is poorly perfused, resulting in altered nutrient availability, yet how this metabolic stress shapes the ECM and its biological activity remains largely unknown. Herein, using murine and patient-derived fibroblasts, we demonstrate that glutamine, a key amino acid depleted in poorly perfused PDAC regions, regulates the biochemical composition, mechanical properties, and biological activity of fibroblast-derived ECM. As glutamine availability decreases, fibroblasts shift from producing an interstitial, mature ECM enriched in fibrillar collagens toward a basement membrane-like ECM. Consistent with these observations, glutamine stress inversely correlates with fibrillar collagen expression in CAFs in patients with PDAC. ECM produced under low glutamine conditions is depleted in collagen I, more elastic, and promotes PDAC cell growth compared to ECM generated under glutamine-rich conditions. Reducing the stiffness of such matrices is sufficient to increase PDAC cell growth. Glutamine-dependent changes in ECM composition, stiffness, and biological activity are driven in part by glutamine-regulated alpha-ketoglutarate availability in fibroblasts. These findings establish nutrient availability as a key regulator of ECM biology and suggest the nutrient-dictated ECM as a novel mechanism by which glutamine stress in the tumor microenvironment shapes cancer cell behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.